Revenue: The sum of all revenue fields included for a company's operating activities.
Bio-Rad Laboratories, Inc. (BIO) had Revenue of $585.40M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$585.40M |
$64.00M |
|
$279.40M |
|
$306.00M |
|
$561.70M |
|
$23.70M |
|
$59.70M |
|
$83.40M |
|
$51.60M |
|
$64.00M |
|
$64.00M |
|
$64.00M |
|
$24.80M |
|
$23.70M |
|
$23.70M |
|
27.94M |
|
27.95M |
|
$2.29 |
|
$2.29 |
|
| Balance Sheet Financials | |
$3.04B |
|
$528.50M |
|
$6.49B |
|
$9.53B |
|
$506.60M |
|
$1.20B |
|
$2.34B |
|
$2.85B |
|
$6.68B |
|
$5.97B |
|
$6.68B |
|
27.63M |
|
| Cash Flow Statement Financials | |
$129.90M |
|
$2.90M |
|
$-97.70M |
|
$489.80M |
|
$523.10M |
|
$33.30M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.99 |
|
-- |
|
-- |
|
0.15 |
|
0.18 |
|
52.27% |
|
4.05% |
|
4.05% |
|
-- |
|
14.25% |
|
10.93% |
|
$95.50M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.35 |
|
1.38 |
|
65.29 |
|
0.96% |
|
1.07% |
|
0.67% |
|
0.81% |
|
$241.72 |
|
$3.42 |
|
$4.65 |
|